Vistin Pharma ASA
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.
Vistin Pharma ASA (VISTN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.022x
Based on the latest financial reports, Vistin Pharma ASA (VISTN) has a cash flow conversion efficiency ratio of 0.022x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr6.37 Million) by net assets (Nkr294.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vistin Pharma ASA - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Vistin Pharma ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vistin Pharma ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vistin Pharma ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ICC Holdings Inc
NASDAQ:ICCH
|
0.113x |
|
Gentian Diagnostics AS
OL:GENT
|
0.208x |
|
Ambika Cotton Mills Limited
NSE:AMBIKCO
|
0.179x |
|
Hong Leong Capital Bhd
KLSE:5274
|
-0.159x |
|
Aprogen KIC Inc
KO:007460
|
-0.041x |
|
SDN Company. Ltd
KQ:099220
|
-0.022x |
|
CAPITAL + REGIONAL LS-01
F:XC2R
|
N/A |
|
Eusu Holdings
KO:000700
|
0.031x |
Annual Cash Flow Conversion Efficiency for Vistin Pharma ASA (2016–2024)
The table below shows the annual cash flow conversion efficiency of Vistin Pharma ASA from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr309.53 Million | Nkr107.86 Million | 0.348x | +24.15% |
| 2023-12-31 | Nkr322.77 Million | Nkr90.59 Million | 0.281x | +964.87% |
| 2022-12-31 | Nkr273.26 Million | Nkr-8.87 Million | -0.032x | -165.44% |
| 2021-12-31 | Nkr275.89 Million | Nkr13.68 Million | 0.050x | +109.27% |
| 2020-12-31 | Nkr272.40 Million | Nkr-145.73 Million | -0.535x | -1267.99% |
| 2019-12-31 | Nkr413.40 Million | Nkr18.93 Million | 0.046x | +140.47% |
| 2018-12-31 | Nkr348.85 Million | Nkr-39.48 Million | -0.113x | -243.02% |
| 2017-12-31 | Nkr120.16 Million | Nkr9.51 Million | 0.079x | -72.57% |
| 2016-12-31 | Nkr186.61 Million | Nkr53.84 Million | 0.288x | -- |